Although SOD1-dependent forms of ALS are more vulnerable to excitotoxicity than other forms of the disease, it has long been known that the glutamate reuptake system, particularly GLT-1, is dysregulated across patients with ALS.7 The gene discussed is SLC1A2; the disease is amyotrophic lateral sclerosis.